Costimulation of T-cell proliferation by a chimeric B7-antibody fusion protein

Cancer Immunology Immunotherapy

Volumn 45, Issue 3-4, 1997, Pages 156-158

  Gerstmayer, Bernhard ^a   Hoffmann, Michael ^a   Altenschmidt, Uwe ^a   Wels, Winfried ^a  

^a TUMOR BIOLOGY CENTER   (Germany)

Author keywords

B7; CD80; CD86; Immunotherapy; Single chain antibody

Indexed keywords

CHIMERIC ANTIBODY; GROWTH FACTOR RECEPTOR; HYBRID PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIBODY PRODUCTION; ARTICLE; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; YEAST;

ANTIBODIES, BISPECIFIC; HLA-B7 ANTIGEN; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOCYTE ACTIVATION; PICHIA; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES;

EID: 0030853154     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050421     Document Type: Article

References (12)

1. Chen L, Ashe S, Brady WA, Hellström I, Hellström KE, Ledbetter JA, McGowan P, Linsley PS (1992) Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71:1093
2. Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA, Lombard LA, Gray GS, Nadler LM (1993) Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909
3. Gerstmayer B, Altenschmidt U, Hoffmann M, Wels W (1997) Costimulation of T-cell proliferation by a chimeric B7-2-antibody fusion protein specifically targeted to cells expressing the erbB2 proto-oncogene. J Immunol 158:4584
4. Gerstmayer B, Pessara U, Wels W (1997) Construction and expression in the yeast Pichia pastoris of functionally active soluble forms of the human costimulatory molecules B7-1 and B7-2 and the B7 counter-receptor CTLA-4. FEBS Lett 407:63
5. Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP (1992) CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607
6. Hynes NE (1993) Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy. Semin Cancer Biol 4:19
7. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA (1991) Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 173:721
8. Moritz D, Wels W, Mattern J, Groner B (1994) Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells. Proc Natl Acad Sci USA 91:4318
9. Rudd CE, Janssen O, Cai YC, Silva AJ da, Raab M, Prasad KV (1994) Two-step TCR zeta/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases. Immunol Today 15:225
10. Wels W, Harwerth IM, Mueller M, Groner B, Hynes NE (1992) Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor. Cancer Res 52:6310
11. Wels W, Harwerth IM, Zwickl M, Hardman N, Groner B, Hynes NE (1992) Construction, bacterial expression and characterization of a bifunctional single-chain antibody-phosphatase fusion protein targeted to the human erbB-2 receptor. Biotechnology 10:1128
12. Yang G, Hellström KE, Hellström I, Chen L (1995) Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules. J Immunol 154:2794